These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16301113)

  • 1. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
    Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
    Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
    Mariani S; Lionetto L; Cavallari M; Tubaro A; Rasio D; De Nunzio C; Hong GM; Borro M; Simmaco M
    Int J Mol Sci; 2014 Jan; 15(1):1433-40. PubMed ID: 24451130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg.
    Scattoni V; Montironi R; Mazzucchelli R; Freschi M; Nava L; Losa A; Terrone C; Scarpa RM; Montorsi F; Pappagallo G; Rigatti P
    BJU Int; 2006 Jul; 98(1):54-8. PubMed ID: 16831143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
    Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research.
    Marshall JR
    IARC Sci Publ; 2001; 154():191-8. PubMed ID: 11220658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison.
    Cui K; Li X; Du Y; Tang X; Arai S; Geng Y; Xi Y; Xu H; Zhou Y; Ma W; Zhang T
    Oncotarget; 2017 May; 8(22):36674-36684. PubMed ID: 28415774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
    Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
    Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycopene in the prevention of prostate cancer.
    Dahan K; Fennal M; Kumar NB
    J Soc Integr Oncol; 2008; 6(1):29-36. PubMed ID: 18302908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.
    Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C
    Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
    Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
    Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
    Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine prostatic intraepithelial neoplasia: is the comparative model relevant?
    Madewell BR; Gandour-Edwards R; DeVere White RW
    Prostate; 2004 Feb; 58(3):314-7. PubMed ID: 14743472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.
    Schwenke C; Ubrig B; Thürmann P; Eggersmann C; Roth S
    J Urol; 2009 Mar; 181(3):1098-103. PubMed ID: 19150092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.